EPO Patents = 2

Forward Citations = 15

Loading Chart...

6 inventors (with patents filed for the assignee):

Thomas Hallam (4 out of 4 patents)

John J Rodenrys (4 out of 10 patents)

Robin M Jackman (3 out of 15 patents)

4. Geert W Schmid-Schonbein (2 out of 9 patents)

5. Yung-Tsai (Andrew) Lee (2 out of 4 patents)

6. Jeng Wei (2 out of 6 patents)

7. Robin Jackman (0 patent)

8. Robin Jackman (0 patent)

6 patents: Sort by Forward Citations

1. 11439611 - Administration of serine protease inhibitors to the stomach (2022-09-13),

2. 11202768 - Compositions and methods for treating and preventing adhesions and ileus (2021-12-21),

3. 11123317 - Compositions for the treatment of autodigestion (2021-09-21),

4. 10772861 - Administration of serine protease inhibitors to the stomach (2020-09-15),

5. 9775821 - Compositions for the treatment of autodigestion (2017-10-03),

6. 9314442 - Compositions for the treatment of autodigestion (2016-04-19),

Leading Biosciences, Inc. is a biopharmaceutical company focused on developing novel therapeutics for the treatment of gastrointestinal disorders. Their flagship product, LB1148, is a first-in-class drug designed to reduce inflammation and improve gut barrier function. With a strong pipeline of innovative products, the company is committed to advancing the field of biosciences and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#167 in Carlsbad, CA

#10,293 in California

#43,795 in US

Carlsbad, CA, United States of America

Leading Biosciences, Inc.